Abstract
The goal of this study was to investigate the isolated and combined effect of ebselen and Hg2+ on calcium influx and on glutamatergic system. We examined the in vitro effects of 2 phenyl-1,2-benzisoselenazol-3(2H)-ona), (Ebselen) on 45Ca2+ influx in synaptosomes of rat at rest and during depolarization and glutamate uptake into synaptosomes. Entry of 45Ca was measured during exposure to mercury in non-depolarizing and depolarizing solutions. Ebselen abolished the inhibition of 45Ca2+ influx on non-depolarizing conditions; however, ebselen did no modify inhibition uptake of 45Ca2+caused by Hg2+ in high K+ depolarizing medium. Ebselen did not modify glutamate uptake inhibition caused by Hg2+ in synaptosomes. These results indicate that ebselen has an in vitro protective effect against Hg2+ induced inhibition of Ca2+ influx into synaptosomes, depending on the depolarizing conditions of the assay. The effects of Hg2+ on glutamate uptake were not modified by ebselen, suggesting that its protection is dependent on the target protein considered.
Similar content being viewed by others
REFERENCES
WHO, Environmental Health Criteria 101:1990. Methylmercury, World Health Organization, Geneve.
Clarkson, T. W. 1997. The toxicology of mercury. Crit Rev. Clin. Lab. Sci., 34:369-403.
Goldman L. R. and Shannon, M. W. 2001. American Academy of Pediatrics:Committee on Environmental Health Technical report:mercury in the environment:Implications for pediatricians. Pediatrics, 108:197-205.
El-Demerdash, F. M. 2001. Effects of selenium and mercury on the enzymatic activities and lipid peroxidation in brain, liver, and blood of rats. J. Environ. Sci. Health, B 36:489-499.
Tchounwou, P. B., Aysun, W. K., Ninashvili, N., and Sutton, D. 2003. Environmental exposure to Mercury and its toxicopathologic implications for public health. Environ Toxicol. 18:49-75.
Klein, R., Sheldon, P. H., Brubaker, P. E., and Lucier, G. W. 1972. A model of acute methyl mercury intoxication in rats. Arch Pathol. 93:408-429.
Levesque, P. C., Hare, M. F., and Atchison, W. D. 1992. Inhibition of mitochondrial Ca2+ release diminishes the effectiveness of methyl mercury to release acetylcholine from synaptosomes. Toxicol Appl. Pharmacol. 115:11-20.
Rocha, J. B. T., Pereira, M. E., Emanuelli, T., Christofari, R. S., and Souza, D. O. 1995. Effect of treatment with mercury chloride and lead acetate during the second stage of rapid postnatal brain growth on δ-aminolevulinic acid dehydratase (ALA-D)activity in brain liver, kidney and blood of suckling rats. Toxicology 1001(3):27-37.
Hrdina, P. D., Peters, D. A. V., and Singhal, R. L. 1976. Effects of chronic exposure to cadmium, lead and mercury on brain biogenic amines in the rat. Res. Comm. in Chem. Pathol. Pharmacol. 15:483-493.
Denny M. F. and Atchison, W. D. 1996. Mercurial-induced alterations in neuronal divalent cation homeostasis. Neuro-Toxicology 17:47-62.
Nicotera, P., Bellomo, G., and Orrenius S. 1992. Calcium mediated mechanisms in chemically induced cell death. Ann. Rev. Pharmacol Toxicol. 32:449-70.
Atchison, W. D. and Hare, M. F. 1994. Mechanisms of methylmercury-induced neurotoxicity. FASEB J. 8:622-629.
Costa, L. G. 1998. Signal transduction in environmental neurotoxicity. Annu. Rev. Pharmacol Toxicol. 38:21-43.
Sirois, J. E. and Atchison, W. D. 1996. Effects of mercurials on ligand-and voltage-gated ion channels: A review. Neuro-Toxicology 17:63-84.
Hewett, S. J. and Atchison, W. D. 1992. Effects of charge and lipophilicity on mercurial-induced reduction of 45Ca2+ uptake in isolated nerve terminals of the rat. Toxicol Appl. Pharmacol. 113:267-273.
Busselberg, D. 1995. Calcium channels as target sites of heavy metals. Toxicol. Lett. 82–83:255-261.
Rossi, A. D., Larsson, O., Manzo, L., Orrenius, S., Vahter, M, Berggren P., and Nicotera, P. 1993 Modifications of Ca2+ signaling by inorganic mercury in PC12 cells. FASEB J. 7:1507-1514.
Hare, M., and Cooper, G. P., and Minnema, D. 1986. Effects of mercury on neurotransmitter release in rat striatal synaptosomes and frog skeletal neuromuscular junction. Toxicology 6:195-201.
Atchison, W. D. 1987. Effects of activation of sodium and cal-cium entry on spontaneous release of acetylcholine induced by methylmercury. J. Pharmacol. Exp. Ther. 241:131-139.
Kapoor, V., Nakahara, D., Blood, R., and Chalmers, J. P. 1990. Preferential release of neuroactive aminoacids from the ventrolateral medulla of the rat in vivo as measured by microdialysis. Neuroscience 37:187-191.
Rajjanna, B. and Hobson, M. 1995. Influence of mercury on uptake of ( 3H)-dopamine and (3H)-norepinephrine by rat brain synaptosomes. Toxicol. Lett., 27:7-14.
Gassó, S., Suñol, C., Sanfeliu, C, Rodriguez-Farré, E., and Cristófol, R. M. 2000. Pharmacological characterization of the effects of methylmercury and mercuric chloride on spontaneous noradrenaline release from rat hippocampal slices. Life Sciences 67:1219-1231.
Danbolt, N. C. 2001. Glutamate uptake. Prog. Neurobiol. 65:1-105.
Brookes, N. 1988. Specificity and reversibility of the inhibition by HgCl2 of glutamate transport in astrocyte cultures. J. Neurochem. 5094:1117-22.
Kim, P. and Choi, B. H. 1995. Selective inhibition of glutamate uptake by mercury in cultured mouse astrocytes. Yonsei Med. J. 36:299-305.
Albrecht J. and Matyja E., 1996. Glutamate:A potential mediator of inorganic mercury neurotoxicity. Metab. Brain. Dis. 11:175-84.
Yallapragada, P. R., Rajanna, S., Fail, S., and Rajanna, B. 1996. Inhibition of calcium transport by mercury salts in rat cerebellum and cerebral cortex in vitro. J. Appl. Toxicol. 16:325-330.
Juárez, B. I., Martinez, M. L., Montante, M., Dufour, L., Garcia, E., and Jiménez-Capdeville, M. E. 2002. Methylmercury increases glutamate extracellular levels in frontal córtex of awake rats, Neurotoxicol. Teratol. 5516:1-5.
Wang, J. F., Komarov, P., Sies., and H. de Groot, H. 1992. Inhibition of superoxide and nitric oxide release and protection from reoxygenation injury by Ebselen in rat Kupfeer cells. Hepatology 15:1112-6.
Parnham, M. and Sies, H. 2000. Ebselen:prospective therapy for cerebral ischaemia. Expert Opin. Investig. Drugs 9:607-619.
Gladilin, S., Bidmon, H. J., Divanach, A., Arteel, G. E., Witte, O. W., Zilles, K., and Sies, H. 2000. Ebselen lowers plasma interleukin-6 levels and glial heme oxygenase-1 expression after focal photothrombotic brain ischemia. Arch Biochem Biophys. 15:237-242.
Rossato, J. I., Zeni, G., Mello, C. F., Rubin, M. A., and Rocha, J. B. T. 2002. Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolionic acid administration in the rat. Neurosci. Lett. 318:137-140.(a)
Rossato, J. L., Ketzer, L. A., Centuriaõo, F. B., Silva, S. J. N., Ludtke, D. S., Zeni, G., Braga A. L., Rubin, M. A., and Rocha, J. B. T. 2002. Antioxidant properties of new chalcogenides against lipid peroxidation in rat brain. Neurochem Res. 27:297-303.
Nogueira, C. W., Quinhones, E. B., Jung, E. A., Zeni, G., and Rocha, J. B. T. 2003. Anti-inflammatory and antinociceptive activity of diphenyldiselenide. Inflamm. Res. 52:56-63.
Sies, H. 1993. Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radic Biol. Med. 14:313-323.
Dawson, D. A., Masayasu, H., Graham, D. I., and Macrae, I. M. 1995. The neuroprotective eficacy of ebselen (a glutathione peroxidase mimic)on brain damage induced by transient focal cerebral ischaemia in the rat. Neurosc. Lett. 185:65-69.
Yamaguchi, T., Sano, K., Takakura, K., Saito, I., Shinohara, Y., Asano, T., and Yasuhara, H. 1998. Ebselen in acute ischemic stroke:a placebo-controlled, double-blind clinical trial. Stroke 29:12-17.
Davalos, A. 1999. New treatments in cerebrovascular diseases. Neurologia 14:77-83.
Namura, S., Nagata, I., Takami, S., Masayasu, H., and Kikuchi, H. 2001. Ebselen reduces cytochrome c release from mito-chondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke 32:1906-11.
Farina, M., Dahm, K. C. S., Schwalm, F. D., Brusque, A. M., Frizzo, M. E. S., Zeni, G., Souza, D. O., and Rocha, J. B. T. 2003. Methylmercury increases glutamate release from brain synaptosomes and glutamate uptake by cortical slices from suckling rat pups:modulatory effect of ebselen. Toxicol Sci. 73:135-140(a)
Farina, M., Frizzo, M. E., Soares, F. A., Schwalm, F. D. Dietrich, M. O., Zeni, G., Rocha, J. B. T., and Souza, D. O. 2003. Ebselen protects methylmercury-induced inhibition of glutamate uptake by cortical slices from adult mice. Toxicol Lett. 144:351-7. (b)
Moretto, M. B., Rossato, J. I., Nogueira, C. W., Zeni, G., and Rocha, J. B. T. 2003. Voltage-dependent Ebselen and diorganochalcogenides inhibition of 45Ca2+ influx into brain synaptosomes is voltage-dependent. J. Biochem. Molecular Toxicol. 17:154-160.
Engman, L. 1959. Expedient synthesis of Ebselen and related compounds. J. Org. Chem. 54:2964-2966.
Rocha, J. B. T., Mello, C. F., Sarkis, J. J. F., and Dias, R. D. 1990. Undernutrition during the preweaning period changes calcium ATPase and ADPase activities of synaptosomal fractions of weaning rats. Brit. J. Nutr. 63:273-283.
Bradford, M. M. 1976. A rapid and sensitive method for quantitative of microgram quantities of protein utilizing the principle of protein dye dinding. Anal Biochem. 72:248-254.
Eason, K. E. and Aronstam, R. S. 1984. Influence of sulfhydryl reagents on potassium-stimulated calcium uptake by rat brain synaptosomes. Res. Comm. Chem. Pathol. and Pharmacol. 44:503-506.
Shank, R. P. and Campbell, G. L. 1984. ά Ketoglutarate and Malate Uptake and Metabolism by Synaptosomes:Further Evidence for an Astrocyte-to-Neuron Metabolic shuttle. J. Neurochem. 42:1153-1161.
Sirois, J. E. and Atchison, W. D. 2000. Methylmercury affects multiple subtypes of calcium channels in rat cerebellar granule cells. Toxicol Appl. Pharmacol. 167:1-11.
Nachshen, D. A. 1984. Selectivity of the Ca ++ binding site in synaptosome Ca ++ channels. Inhibition of Ca influx by multivalent metal cations. J. Gen. Physiol. 83:941-967.
Kauppinen, R. A., Komulainen, H., and Taipale, H. T. 1989. Cellular mechanisms underlying the increase in cytosolic free calcium concentration induced by methylmercury in cerebrocortical synaptosomes from guinea pig. J. Pharmacol. Exp. Ther. 248:1248-1254.
Atchison, W. D. 1986. Extracellular calcium-dependent and—independent effects of methylmercury on spontaneous and potassium-evoked release of acetylcholine at the neuromuscular junction. J. Pharmacol. Exp. Ther. 237:672-680.
Aschner, M., Eberle, N. B., Miller, K., and Kimelberg, H. K. 1990. Interactions of methylmercury with rat primary astrocyte cultures—inhibition of rubidium and glutamate uptake and induction of swelling. Brain Res. 530:245-250.
Nagaraja, T. N. and Brookes, N., 1996. Mercuric chloride uncouples glutamate uptake from the countertransport of hydroxyl equivalents. Am. J. Physiol. 40C:1487-C-1493.
Bosch-Morell, F., Roma, J., Puertas, F. J., Marin, N., Diaz-Llopis M., and Romero, F. J. 1999. Efficacy of the anti-oxidant ebselen in experimental uveitis. Free. Rad. Biol. Med. 27(3-4):388-91.
Bosch-Morell, F., Roma, J., Marin, N., Romero, B., Rodriguez-Galietero A., Johnsen-Soriano, S., Diaz-Llopis, M., and Romero, F. J. 2002. Role of oxygen and nitrogen species in experimental uveitis:Anti-inflammatory activity of the synthetic antioxidant ebselen. Free Radic. Biol. Med. 1, 33(5):669-75
Cotgreave, I. A., Duddy, S. K., Kass, G. E. N., Thompson, D., and Moldeus, P. 1989. Studies on the anti-inflammatory activity of ebselen—ebselen interferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C. Biochem. Pharmacol. 38(4):649-656.
Hattori, R., Inoue, R., Sase, K., Eizawa, H., Kosuga, K., Aoyama, T., Masayasu, H., Kawai, C., Sasayama, S., and Yui, Y. 1994. Preferential inhibition of inducible nitric oxide synthase by ebselen. Eur. J. Pharmacol. 267:R1-R2.
Schewe, C., Schewe, T., and Wendel, A. 1994. Strong inhibition of mammalian lipoxygenases by the anti-infl ammatory seleno-organic compound ebselen in the absence of glutathione. Biochem. Pharmacol. 48:65-74.
Takasago T., Peters, E. E., Graham, D. I., Masayasu, H., and Macrae, I. M. 1997. Neuroprotective efficacy of ebselen, an anti-oxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion. Br. J. Pharmacol. 122(6):1251-6.
Mugesh, G., du Mont, W. W., and Sies, H. 2001. Chemistry of biologically important synthetic organoselenium compounds. Chem. Rev. 101(7):2125-2179.
Zhao R. and Holmgren, A. 2002. A novel antioxidant mechanism of ebselen involving ebselen diselenide, a substrate of mammalian thioredoxin and thioredoxin reductase. J. Biol. Chem. 277(42):39456-62.
Zhao, R., Masayasu, H., and Holmgren, A. 2002. Ebselen:a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thior-edoxin oxidant. Proc Natl. Acad. Sci. 99(13):8579-84.
Binah, O., Meiri, U., and Rahamimoff. 1978. The effects of HgCl2 and mersalyl on mechanisms regulating intracellular calcium and transmitter release. Eur J. Pharmacol. 51(4):453-7.
Levesque, P. C., Atchison, W. D. 1991. Disruption of brain mitochondrial calcium sequestration by methylmercury. J. Pharmacol Experim. Therap. 256(1):236-242.
Ichida, S., Kuo, C. H., and Yoshida, H. 1980. Subsynaptosomal distribution of 45Ca++ taken up by synaptosomes in high-potassium mediumn. Neurochem Res. 5(4):433-9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moretto, M.B., Franco, J., Posser, T. et al. Ebselen Protects Ca2+ Influx Blockage But Does Not Protect Glutamate Uptake Inhibition Caused By Hg2+ . Neurochem Res 29, 1801–1806 (2004). https://doi.org/10.1023/B:NERE.0000042205.08917.f2
Issue Date:
DOI: https://doi.org/10.1023/B:NERE.0000042205.08917.f2